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Abstract
Background: Epidemiological studies have consistently established high comorbidity between psychiatric disorders
and substance use disorders (SUD). This comorbidity is even more prominent when psychiatric populations are
studied. Previous studies have focused on inpatient populations dominated by psychotic disorders, whereas this
paper presents findings on patients in Community Mental Health Centres (CMHCs) where affective and anxiety
disorders are most prominent. The purpose of this study is to compare patients in CMHCs with and without SUD
in regard to differences in socio-demographic characteristics, level of morbidity, prevalence of different diagnostic
categories, health services provided and the level of improvement in psychiatric symptoms.
Methods: As part of the evaluation of the National Plan for Mental Health, all patients seen in eight CMHCs during
a 4-week period in 2007 were studied (n = 2154). The CMHCs were located in rural and urban areas of Norway.
The patients were diagnosed according to the ICD-10 diagnoses and assessed with the Health of the Nation
Outcome Scales, the Alcohol Use Scale and the Drug Use Scale.
Results: Patients with SUD in CMHCs are more frequently male, single and living alone, have more severe
morbidity, less anxiety and mood disorders, less outpatient treatment and less improvement in regard to recovery
from psychological symptoms compared to patients with no SUD.
Conclusion: CMHCs need to implement systematic screening and diagnostic procedures in order to detect the
special needs of these patients and improve their treatment.
Background
Epidemiological studies have consistently established
high comorbidity between psychiatric disorders and sub-
stance use disorders (SUD) [1-5]. By SUD we refer to
abuse, dependence and addiction from both alcohol and
other substances. This comorbidity is even more pro-
nounced in clinical populations, particularly among
homeless groups [6] and in acute psychiatric wards [7,8]
where patients with schizophrenia are particularly fre-
quent. The prevalence of SUD varies considerably
between studies, i.e. 24-50% [7-9]. This is explainable by
differences in substance use levels in the catchment
areas and by intake policies. Another explanation could
be insufficient diagnostic practice [10]. Several studies
have found under-diagnosis of SUD in psychiatric hospi-
tals [11,12]. There is also evidence that this group of
patients do not receive health services according to their
needs. Harris and Edlund found that mental health pro-
grams provided substance use services to only 31% of
the clients evidencing severe mental illness with SUD
[13].
These investigations have laid a sound basis for the
knowledge on comorbidity among inpatient populations.
Little, however, is known about the prevalence of SUD
in Community Mental Health Centres (CMHCs), where
the clinical population differs from that of an acute psy-
chiatric ward by having predominantly anxiety disorders
and non-psychotic affective disorders. Further, it is
insufficiently studied whether patients with substance
use disorders differ from patients without such comor-
bidity and whether the CMHCs differentiate their treat-
ment accordingly.
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In a recent study of CMHCs in Norway, we found that
only 10% of the patients had received ICD-10 diagnoses
[14] of SUD [15]. The obvious explanation was under-
detection by the clinicians. In addition to the ICD-10
diagnoses, the centres used the Health of the Nation
Outcome Scales (HoNOS) which includes a score on
substance use problems, the Alcohol Use Scale (AUS)
and the Drug Use Scale (DUS). There were some discre-
pancies between these measures regarding which
patients were scored as having a clinical problematic use
of alcohol and/or drugs. By combining these measures,
however, we were able to identify all patients that were
scored as having a clinically significant use of alcohol
and/or other substances or diagnosed with a substance
use disorder. These patients were defined as the SUD
group. Patients that received a low score, indicating no
clinical problem, on the substance use measures and did
not receive an ICD-10 diagnosis of SUD were defined as
the No SUD group. Hence, the grouping variable con-
sists of the HoNOS, the AUS and the DUS, all validated
measures, together with the ICD-10 diagnoses, which
were based on routine clinical assessments.
In this paper we compare the SUD group with the No
SUD group
The aims of this paper are to compare the patients in
CMHCs with and without SUD in regard to 1) differ-
ences in socio-demographic characteristics, 2) the level
of morbidity, 3) the prevalence of different diagnostic
categories, 4) differences in health services provided and
5) differences in the level of improvement in psychiatric
symptoms.
Methods
Study design
This is a cross-sectional study based upon data from the
evaluation of the National Plan for Mental Health
[16,17]. In the original study, eight Community Mental
Health Centres (CMHCs) in both rural and urban areas
of Norway were investigated during three separate 4
week periods in 2002, 2005 and 2007. Their total catch-
ment area was about 450 000 inhabitants, i.e. about 10%
of the Norwegian population. Specific forms were com-
pleted by clinicians, general practitioners, patients and
their relatives. For this paper, we have focused on the
clinician assessment forms from 2007.
The clinicians at the CMHCs, i.e. psychiatrists, psy-
chologists, psychiatric nurses and clinical social workers,
were asked to complete standardized forms for all inpa-
tients and outpatients seen within the four week period.
A total of 2154 patients were included. This was about
half of all patients reported to the National Patient Reg-
ister (NPR) from these CMHCs in a similar 4-week per-
iod a few months later, as NPR data from the study
period was unavailable. We had no information on eligi-
ble patients not included in the study. Details on the
methodology are described elsewhere [15].
Research instruments
Demographic, administrative and clinical information
was recorded for each patient. One primary and two
secondary ICD-10 diagnoses [14] were recorded on the
basis of routine clinical assessments. No structured clini-
cal interview was used. The Health of the Nations Out-
come Scales (HoNOS) [18,19] were used to measure
severity of psychiatric problems in 12 areas including
substance use. The scale ranges from “no problem”
(score 0) through “mild but clinically significant pro-
blem” (score 2) to “severe problem” (score 4). The Alco-
hol Use Scale (AUS) and the Drug Use Scale (DUS)
[20,21] were used to rate the severity of alcohol and
drug use, respectively. These are 5 point scales ranging
from “abstinence” (score 1) through “abuse” (score 3) to
“addiction with hospitalization” (score 5). Before the
first two surveys in 2002 and 2005, the clinicians at the
eight CMHCs were trained in rating the HoNOS, the
AUS and the DUS. Before each of the three surveys they
had an optional practice on case vignettes. In 2002,
intraclass correlation coefficients (ICC) for the HoNOS
were calculated and ranged from 0.60 to 0.89 for the
subscales (T. Ruud, personal communication). These
coefficients were considered acceptable [22,23]. We
found the same prevalence rates of SUD measured by
the ICD-10 diagnoses, the HoNOS, the AUS and the
DUS between 2002 and 2007, hence we concluded there
was consistency in how these instruments were used
between these years [15].
Substance use variables
We defined the SUD group as having fulfilled one or
more of the following criteria: 1) a diagnosis of a sub-
stance related disorder, ICD-10 F10-19, as first, second
or third diagnosis, 2) a high degree of alcohol and/or
drug use measured by the HoNOS item three, scored 2-
4, 3) a high degree of alcohol use measured by the AUS,
scored 3-5, or 4) a high degree of drug use measured by
the DUS, scored 3-5. The No SUD group was defined by
not fulfilling any of the above criteria.
Socio-demographic variables
The socio-demographic variables consisted of age, gen-
der, paid work (yes/no), in relationship (yes/no), living
alone (yes/no) and ethnicity (Norwegian / non-Norwe-
gian). No paid work was defined as “in education”,
“working at home”, “on rehabilitation benefit”, “on dis-
ability benefit”, “on retirement pension” and “other”. In
relationship was defined as “married” or “cohabitant”,
while not in relationship was defined as “unmarried”,
“widowed”, “separated” or “divorced”.
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Variables regarding the level of morbidity
The variables about the patients’ level of morbidity were
the HoNOS (except the substance use item). The sub-
stance use item of the HoNOS was used as one of the
SUD group defining criteria. We categorized the HoNOS
scores into two groups: 1) no clinically relevant problem
(scores 0-1) and 2) clinically relevant problem (scores 2-
4).
Variables regarding the prevalence of different diagnostic
categories
The ICD-10 diagnoses were grouped into psychotic dis-
orders (F20-29), mood disorders (F30-39), anxiety disor-
ders (F40-49), personality disorders (F60-69) and other
psychiatric disorders (F50-59, F70-99)
Variables regarding the health services provided
The variables about the health services provided con-
sisted of psychiatric healthcare received during the last
12 months and additional questions about the services in
total. The original 6 items of psychiatric healthcare
received during the last 12 months were categorized into
3 groups; “outpatient or day service at CMHC”, “inpati-
ent service at CMHC or hospital” and “outpatient or
inpatient addiction treatment”. They were scored as
“no”, “0-6 months”, “7-11 months” and “all the time”.
These categories were dichotomized into “no” and “0-12
months” for the analyses. The additional questions
about the services in total were “is the patient treated at
the right competency level” (scored as “unnecessarily
high”, “right” or “too low”), “are the services sufficiently
comprehensive”, “are the most important needs of the
patient met”, “are several services cooperating in making
an “Individual Plan” for the patient”, and “is the patient
also treated in a psychiatric hospital”. These questions
were scored as “yes / no / I don’t know/ not applicable”.
The latter two options were taken out of the analysis.
An “Individual Plan” means a tailored, comprehensive
treatment plan that all patients with a chronic disease
are entitled to have according to Norwegian law.
Variables regarding the level of improvement from
psychiatric symptoms
The variables were scored on a 7-point scale (1: much
worse, 2: a bit worse, 3: no change, 4: a little change, 5:
better, 6: much better, 7: a lot better). These items were
grouped into two groups: 1) worse / no change (scores
1-3) and 2) better (scores 4-7). This scale is based on
the clinicians’ subjective evaluation of the patients’
improvement on the day of the survey, regardless of
their length of treatment.
Statistics
When comparing two groups the Student’s t-test was
used for continuous variables and the Pearson’s chi-
square test was used for categorical variables. We per-
formed logistic regression analyses to select the
adjustment variables. An a-level of 0.05 was chosen
when deciding which adjustment variables to include.
We included the following variables for the adjusted
analyses; age, gender, in relationship, overactive, aggres-
sive, disruptive or agitated behaviour (honos item 1),
non-accidental self-injury (honos item 2) and problems
with activities of daily living (honos item 10). We also
adjusted for the interaction between age and problems
with activities of daily living. The explanatory variable
“problems with relationships” (honos item 9) was not
adjusted for in relationship, as this was not clinically
meaningful. For the main analyses we did Bonferroni
correction of the alfa-level due to the number of tests to
avoid Type I statistical error. When an explanatory vari-
able lost its significance due to the adjusted analyses, we
ran a series of regression analyses with each adjustment
variable to examine which one resulted in the greatest
change in the beta coefficient of the explanatory vari-
able. Finnally, we performed Generalized Estimating
Equations analyses (GEE) with exchangeable working
correlation and robust variance estimation. This was
done to adjust for nesting within the CMHCs in the
adjusted analyses. The GEE analyses only gave minor
changes in the results compared to the regression ana-
lyses. Because gender was shown to be an important
adjustment factor, we did stratified analyses by gender.
As these analyses only showed small differences in the
odds ratios between men and women, this issue is not
elaborated any further. The analyses were performed
using SPSS version 18.0 [24].
Ethics and consent issues
The study was approved by the Norwegian Data Inspec-
torate and the Norwegian Regional Ethics Committee.
Results
Table 1 shows the background variables of the non-sub-
stance use disorder group, n = 1786, and the substance
use disorder group, n = 368. The mean age amongst the
patients in total was 39.3 years with no statistically sig-
nificant difference between the two groups. The patients
in the SUD group were more often male, less often in a
relationship and more often living alone compared to
the No SUD group. Even though these differences were
statistically significant, the effect-sizes were quite small
[25]. There were no differences in ethnicity between the
two groups.
We examined if the severity of morbidity as measured
by the HoNOS predicted being a SUD patient (table 2).
We found that the SUD group had significantly more
problems with “overactive, aggressive, disruptive or agi-
tated behaviour”, “non-accidental self-injury”, “problems
with relationships”, “problems with activities of daily liv-
ing” and “problems with occupation and activities”.
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These results were not altered when other variables
were adjusted for. The SUD patients also seemed to
have more “cognitive problems” and “problems with liv-
ing conditions”. These results, however, changed to a
non-significant level after adjustment and we found that
gender had the greatest impact in the adjusted analyses.
In this sample only 36.1% of the patients received
more than one diagnosis [15] which would make it diffi-
cult to look at the prevalence of psychiatric disorders
beside SUD. However, our definition of SUD is based
upon the HoNOS, the AUS and the DUS besides the
ICD-10 diagnoses. Consequently, we can look at comor-
bidity between SUD and other illnesses. In the SUD
group, 268 patients (72.8%) received diagnoses of
somatic or psychiatric disorders other than SUD. Having
a mood disorder and having an anxiety disorder was
more common amongst No SUD patients and these
results were not altered after adjustment.
We examined if receiving certain health services pre-
dicted being a SUD patient (table 4). We found that
receiving outpatient or day service at the CMHC was
less common amongst the SUD patients. This result was
not altered when adjusted for other variables. Receiving
inpatient service at the CMHC or hospital was more
common among the SUD patients, and even though the
effect-size (OR) was not altered by more than 0.3 units,
the result was no longer statistically significant after
adjustment. We found that in relationship had the
greatest impact in the adjusted analyses. Receiving out-
patient or inpatient addiction treatment was, not sur-
prisingly, more common among the SUD patients and
this was not altered after adjustment. The SUD patients
were more often reported to be treated at too low a
competency level, and controlling for other variables did
not alter this result. The therapists did not perceive the
SUD patient’s services to be sufficiently comprehensive.
This result, however, was altered to a non-significant
level when adjusted for, even if the change in effect size
was only 0.2 units. We found that overactive, aggressive,
disruptive or agitated behaviour (honos item 1) and pro-
blems with activities of daily living (honos item 10) had
the greatest impact in the adjusted analyses. Having the
patient’s most important needs met was less common
among the SUD patients, but this result also became
non-significant after adjustment even if the effect size
Table 1 Background variables of the non substance use
disorder (No SUD) and substance use disorder (SUD)
groups
Background
variables
No SUDa
N = 1786
SUDa
N = 368
Effect-sizesb p-
valuec
Age 39.4 (12.9) 38.7 (12.9) 0.058 (0.029) 0.312
Male gender 601 (34.9) 196 (55.1) 0.156 < 0.001
Not in relationship 987 (55.9) 266 (73.1) 0.131 < 0.001
Living alone 553 (34.4) 166 (49.6) 0.119 < 0.001
No paid work 1296 (73.5) 287 (79.3) 0.050 0.021
Norwegian 1638 (92.3) 348 (94.8) -0.037 0.088
a) Age is presented as mean (SD) all other variables are presented as n (%).
Valid percentages are given.
b) Cohen’s d (effect size r) is used for age, for all other variables the phi-
coefficient is used
c) The student’s T-test is used for age, for all other variables the c2-test is
used.
Table 2 Prevalence rates, multivariate unadjusted and adjusted odds ratios (OR) with 99.9% confidence intervals (CI)
indicating the odds for being a patient with substance use disorder (SUD) rather than being a patient without SUD in
regard to the level of morbidity measured by the Health of the Nation Outcome Scales
NO SUDa
N = 1786
SUDa
N = 368
Odds ratio
Unadjusted 99.9% CI Adjustedb 99.9% CI
Health of the Nation Outcome Scale
(scores 2-4) Score 0-1 is reference OR = 1
01 - Overactive, aggressive, disruptive or agitated behaviour 131 (7.5) 64 (17.7) 2.7 1.6-4.5 2.3 1. 3-4.0
02 - Non-accidental self-injury 146 (8.3) 57 (15.7) 2.1 1.2-3.5 2.1 1.2-3.8
04 - Cognitive problems 261 (14.9) 79 (22.1) 1.6 1.0-2.6 1.4 0.8-2.2
05 - Physical illness or disability problems 405 (23.0) 95 (26.4) 1.2 0.8-1.8
06 - Problems associated with hallucinations and delusions 205 (11.6) 46 (12.8) 1.1 0.6-2.0
07 - Problems with depressed mood 983 (55.9) 213 (59.2) 1.1 0.8-1.7
08 - Other mental and behavioural problems 988 (73.0) 207 (73.7) 1.0 0.6-1.7
09 - Problems with relationships 974 (55.3) 245 (67.3) 1.7 1.1-2.5 1.6 1.1-2.5
10 - Problems with activities of daily living 517 (29.3) 159 (43.9) 1.9 1.3-2.8 1.6 1.1-2.4
11 - Problems with living conditions 120 (6.8) 54 (14.9) 2.4 1.4-4.2 1.6 0.9-3.1
12 - Problems with occupation and activities 493 (28.1) 149 (41.3) 1.8 1.2-2.6 1.6 1.1-2.4
Odds ratios with p-values < 0.0013 are given in bold face
a The variables are presented as n (%). Valid percentages are given.
b Generalized Estimating Equations are used. All variables are adjusted for age, gender and in relationship except “problems with relationships” which is adjusted
for age and gender.
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was only changed by 0.2 units. Overactive, aggressive,
disruptive or agitated behaviour (honos item 1) and pro-
blems with activities of daily living (honos item 10) had
the greatest impact in the adjusted analyses. Having sev-
eral services cooperating in making an individual plan
for the patient was more common amongst the SUD
patients, but the result became non-significant after
adjustment. Gender and in relationship had the greatest
impact in the adjusted analyses.
We examined if the degree of recovery predicted being
a SUD patient. We found that having no change or
getting worse in regard to “psychological problems” was
more common among SUD patients and this result was
not altered when adjusted for other variables (table 5).
Having “psychiatric problems”, “problems with social
functioning” and “problems with practical functioning”
was also more common amongst SUD patients, but
changed to a borderline significant level after being
adjusted with a change in effect sizes between 0.1-0.3
units. Having no change or getting worse in regard to
“problems with close relations” was more common
amongst the SUD patients, but changed to a non
Table 3 Prevalence rates, multivariate unadjusted and adjusted odds ratios (OR) with 99.9% confidence intervals (CI)
indicating the odds for being a patient with substance use disorder (SUD) rather than being a patient without SUD in
regard to type of psychiatric diagnosis received
Having received a psychiatric diagnosis
Not having the disorder is reference OR = 1
No SUDa
N = 1786
SUDa
N = 368
Odds ratios
Unadjusted 99.9% CI Adjustedb 99.9% CI
Psychotic disorder 243 (13.8) 39 (10.7) 0.8 0.4-1.4
Mood disorder 817 (46.5) 123 (33.9) 0.6 0.4-0.9 0.7 0.4-1.0
Anxiety disorder 684 (38.9) 83 (22.9) 0.5 0.3-0.7 0.5 0.3-0.8
Personality disorder 294 (16.7) 53 (14.6) 0.9 0.5-1.4
Other psychiatric disorder 233 (13.3) 41 (11.3) 0.8 0.5-1.5
Odds ratios with p-values < 0.0013 are given in boldface
aThe variables are presented as n (%). Valid percentages are given.
b Generalized Estimating Equations are used. All variables are adjusted for age, gender and in relationship
Table 4 Prevalence rates, multivariate unadjusted and adjusted odds ratios (OR) with 99.9% confidence intervals (CI)
indicating the odds for being a patient with substance use disorder (SUD) rather than being a patient without SUD in
regard to type of health services received
No SUDa
N = 1786
SUDa
N = 368
Odds ratios
Unadjusted 99.9%
CI
Adjustedb 99.9%
CI
Type of psychiatric healthcare received during the last 12 months
No treatment received during the last 12 months is ref. OR = 1
Outpatient or day service at CMHC 1654 (94.4) 259 (77.3) 0.2 0.1-0.3 0.2 0.1-0.4
Inpatient service at CMHC or hospital 372 (25.8) 115 (38.1) 1.8 1.2-2.7 1.5 0.9-2.4
Outpatient or inpatient Addiction treatment 23 (1.7) 148 (46.7) 51.5 23.9-
110.9
55.8 23.8-
130.9
Additional questions about the services in total
The patient is treated at too low a level
Too high a level or sufficient level is reference OR = 1
45 (2.6) 34 (9.4) 4.0 1.9-8.4 2.8 1.1-6.7
The services are sufficiently comprehensive
Not comprehensive is reference OR = 1
1180 (87.3) 218 (76.8) 0.5 0.3-0.8 0.7 0.4-1.4
The patient’s most important needs are met
Important needs are not met is reference OR = 1
1460 (91.5) 267 (82.2) 0.4 0.2-0.7 0.6 0.3-1.1
Several services are cooperating in making an individual plan for the
patient
Not cooperating is reference OR = 1
326 (39.6) 112 (52.1) 1.7 1.0-2.7 1.3 0.7-2.2
The patient is also treated in a psychiatric hospital
Not treated in psych. hospital is reference OR = 1
81 (14.3) 36 (23.1) 1.8 0.9-3.7
Odds ratios with p-values < 0.0013 are given in boldface
aThe variables are presented as n (%). Valid percentages are given.
b Generalized Estimating Equations are used. All variables are adjusted for age, gender, in relationship, Overactive, aggressive, disruptive or agitated behaviour
(honos item 1), Non-accidental self-injury (honos item 2), Problems with activities of daily living (honos item 10) and the interaction term age* problems with
activities of daily living
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significant level after being adjusted, with a change in
effect size of only 0.3 units. We found that gender was
the adjustment factor that was of greatest importance in
changing the significance level of all the explanatory fac-
tors. For the explanatory factors “psychiatric problems”,
“problems with close relations” and “problems with
social functioning” the adjustment factor in relationship
was also of importance.
Discussion
In this study we investigated the treatment of patients
with SUD in Community Mental Health Centres
(CMHCs) which typically treat patients with non-psy-
chotic disorders such as anxiety disorders, non-psychotic
affective disorders, adjustment difficulties and personal-
ity problems. The main findings are that, also in outpa-
tient settings, the SUD group differs from the No SUD
group in several ways not often systematically met with
adequate treatment approaches.
Our first findings are that the patients in the SUD
group are more often male, less often in a relationship
and more often living alone. This is largely consistent
with other epidemiological and clinical studies
[4,5,26-28], except for one study where only the gender
difference was found [29]. These findings indicate that
people with SUD are a more vulnerable group. Conse-
quently, therapists should plan treatment accordingly.
The second finding is that the SUD group has more
severe morbidity as measured by the HoNOS with
higher scores on five out of eleven parameters when
adjusted for age, gender and in relationship. This means
that the SUD group has more problems with aggressive
behaviour, self harm, relationships, occupation and
activities of daily living. It is therefore essential that
these problems are targeted in their treatment plan. We
found one other study targeting CMHCs with compar-
able measures [30]. In this study of patients with schizo-
phrenia in inpatient and outpatient clinics, the misuse
group was found to have higher sum scores on the
HoNOS compared to the non-misuse group. In addition,
Fowler et al found higher mean scores on the Symptom
Check List-90 revised (SCL-90R) [31-33] on all sub-
scores amongst the SUD group compared to the No
SUD group amongst patients with schizophrenia [34].
The third finding is that the SUD patients have lower
prevalences of anxiety and depression compared to
patients without SUD. This finding is in contrast to
most studies in the field indicating a higher prevalence
of most comorbid disorders in SUD patients[1,35,36].
However, Bonsack et al found a similar pattern for anxi-
ety and depression amongst patients in an acute psy-
chiatric ward, but with higher prevalences for other
psychiatric diagnoses amongst the SUD group compared
to the No SUD group [28]. Our finding could have sev-
eral explanations. Firstly, the different CMHCs may
have recruited different numbers of SUD and No SUD
patients due to different catchment areas. Secondly, it
could be a case of competing risks; patients with SUD
need less other morbidity for referral to CMHCs; thus
not reflecting the comorbidity in the general population.
Thirdly, less severe mental illnesses, like anxiety and
depression, with comorbid SUD may be more often
referred to substance use treatment centres. This could
be detrimental to outcome, as patients treated in sub-
stance abuse treatment facilities may not receive ade-
quate attention for their comorbid psychiatric illness.
Bakken et al did a six year follow-up study of substance
abusers in inpatient and outpatient addiction treatment
facilities. They found that the number and specific types
of axis 1 and axis 2 disorders with the level of SUD at
Table 5 Prevalence rates, multivariate unadjusted and adjusted odds ratios (OR) with 99.9% confidence intervals (CI)
indicating the odds for being a patient with substance use disorder (SUD) rather than being a patient without SUD in
regard to recovery
No change or getting worse from:
Getting better is reference OR = 1
No SUDa
N = 1786
SUDa
N = 368
Odds ratios
Unadjusted 99.9% CI Adjustedb 99.9% CI
Psychiatric symptoms 516 (29.3) 155 (42.7) 1.8 1.2-2.6 1.5 1.0-2.2
Psychological symptoms 576 (32.8) 170 (47.0) 1.8 1.2-2.6 1.5 1.0-2.3
Problems with close relations 863 (49.4) 213 (59.0) 1.5 1.0-2.1 1.2 0.8-1.9
Problems with social functioning 702 (40.0) 189 (51.9) 1.6 1.1-2.3 1.5 1.0-2.2
Problems with practical functioning 800 (46.0) 212 (58.9) 1.7 1.1-2.5 1.5 1.0-2.2
Problems with working disability 1050 (60.6) 243 (67.1) 1.3 0.9-1.9
Behavioural problems 1069 (65.9) 243 (70.4) 1.2 0.8-1.9
Odds ratios with p-values < 0.0013 are given in boldface
aThe variables are presented as n (%). Valid percentages are given.
b Generalized Estimating Equations are used. All variables are adjusted for age, gender, in relationship, Overactive, aggressive, disruptive or agitated behaviour
(honos item 1), Non-accidental self-injury (honos item 2), Problems with activities of daily living (honos item 10) and the interaction term age* problems with
activities of daily living
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admission were all independent predictors of a high
level of mental distress at follow-up [37]. This under-
lines the need for good diagnostic and screening rou-
tines along with the competence to treat this
comorbidity in an integrated treatment program.
The fourth and important finding is that patients with
SUD in these CMHCs are treated differently. The
patients in the SUD group receive less outpatient treat-
ment compared to the No SUD group. In addition, the
clinicians rate the patients in the SUD group as being
treated at too low a competency level. One possible
explanation might be that the therapists feel they lack
the competence or the resources to treat these patients
in an outpatient setting. In a phenomenological study of
clinicians in mental health centres Deans et al found
that the clinicians felt unprepared and that they were
lacking knowledge of dual diagnosis patients [38]. This
is in accordance with other studies that describe difficul-
ties in implementing new knowledge and guidelines
regarding comorbid patients in mental health care
[39,40]. This highlights the need for establishing and
implementing good treatment strategies for this group
of patients.
Our final finding is that the patients in the SUD group
have poorer outcomes in regard to recovery from psy-
chological problems. In addition, they have poorer out-
comes on three out of the remaining six items at a
borderline significant level after adjustment for other
variables. This is in accordance with previous findings of
poorer treatment outcomes for patients with co-occur-
ring disorders [41] and is in line with the other findings
of this paper, that is, that these patients have greater
morbidity and receive less adequate help for their
problems.
There are several limitations to this study. This study
is part of an evaluation of the National Plan for Mental
Health that was adapted to the study aims, the preva-
lence of SUD was measured by a composite adapted
approach, and there was no structured clinical interview
used to assess diagnoses. Further, the variables regarding
the level of improvement from psychiatric symptoms
were based on the clinicians’ subjective evaluation of the
patients’ improvement, regardless if the clinician knew
the patient for a longer or shorter period of time. Prior
to the surveys in 2002 and 2005 the clinicians were
trained in using the HoNOS, the AUS and the DUS
while they only had optional training on case vignettes
prior to the survey in 2007. However, comparing the
results from 2007 with the results from 2002 in regard
to the prevalence of SUD measured on the ICD-10 F10-
19 diagnoses, the HoNOS, the AUS and the DUS, we
found no significant differences [15]. For further studies
we would recommend to include screening procedures
for SUD, i.e. the Alcohol Use Identification Test
(AUDIT) [42] and the Drug Use Identification Test
(DUDIT) [43], and valid diagnostic procedures, such as
the Structured Clinical Interview for DSM-IV (SCID)
[44] or the Psychiatric Research Interview for Severe
Mental disorders (PRISM) [45]. One might also include
measures like the HoNOS, the Symptom Check List
(SCL-90R) or the Addiction Severity Index (ASI) [46] to
enable basic comparisons between studies. Finally, the
representativeness of outpatient clinics in Norway might
be questioned, both according to the prevalence and
type of substance use in the catchment areas and the
clinical routines in the units. It is obviously important
to confirm these findings in further studies. However,
the findings underline the need for targeted treatment
approaches for patients comorbid with SUD in psychia-
tric outpatient units.
Conclusion
Patients with SUD in CMHCs are more frequently male,
single and living alone, have a higher level of morbidity,
less anxiety and mood disorders, less outpatient treat-
ment and have less improvement in regard to recovery
from psychological symptoms compared to patients with
no SUD. CMHCs need to implement systematic screen-
ing and diagnostic procedures in order to detect the
special needs of substance abusing patients and improve
their treatment.
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